Pfizer spun off its animal health business, a move related to the animal health sector where Zoetis operates.
13 reports, 3 independent
Updated Aug 29
Gone quiet
Reached 3 outlets in its first 24 hours
- Reports
- 13
- Developments
- 1
- Repetition
- 92%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Pfizer spun off its animal health business, a move related to the animal health sector where Zoetis operates.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Pfizer
American multinational pharmaceutical and biotechnology corporation
-
Zoetis
American animal health company
Nothing else this week.
Related events
- Pfizer is based in New York and Bristol-Myers Squibb is based in Princeton, New Jersey.
- Bristol-Myers Squibb and Pfizer are co-marketing Eliquis, while both companies are noted as dividend payers.
- MarketBeat is providing analyst ratings and tracking the competitive landscape between healthcare companies Pfizer and Lyra Therapeutics.
Coverage
Newest first; wire copies grouped- ZacksIf You Invested $1000 in Zoetis a Decade Ago, This is How Much It'd Be Worth Now For most investors, how much a stock's price changes over time is important. This factor can impact your investment po
- StockStory2 Reasons to Watch ZTS and 1 to Stay Cautious Over the past six months, Zoetis’s shares (currently trading at $156.80) have posted a disappointing 7% loss, well below the S&P 500’s 8.6% gain. This mi
- Motley FoolIf You'd Invested $1,000 in Zoetis (ZTS) Stock 10 Years Ago, Here's How Much You'd Have Today Shares of Zoetis have been roughly average performers over the past decade. The shares seem appealingly v
- Motley FoolGot $1,000? 3 Dividend Stocks to Buy and Hold Forever A leader in animal health trades at its lowest valuation ever. A Dividend King at a great price. A company poised to grow as the general populati
- StockStory3 Large-Cap Stocks with Promising Prospects Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it
- Motley Fool2 Stocks to Buy With $5,000 and Hold for a Decade Zoetis is a leading animal health company and a steady dividend payer. Reddit is seeing its ad business boom, and it's exploring other AI-related rev
- ZacksWhy Zoetis (ZTS) is a Top Growth Stock for the Long-Term Taking full advantage of the stock market and investing with confidence are common goals for new and old investors alike. Many investors also
- StockStoryZoetis (NYSE:ZTS) Posts Better-Than-Expected Sales In Q2, Stock Soars Animal health company Zoetis (NYSE:ZTS) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 4.2% yea
- StockStoryZoetis (ZTS): Buy, Sell, or Hold Post Q1 Earnings? Over the last six months, Zoetis’s shares have sunk to $153.39, producing a disappointing 11.4% loss - a stark contrast to the S&P 500’s 5.8% gain.
- StockStoryWinners And Losers Of Q1: Zoetis (NYSE:ZTS) Vs The Rest Of The Branded Pharmaceuticals Stocks Wrapping up Q1 earnings, we look at the numbers and key takeaways for the branded pharmaceuticals stocks,
- ZacksHere's Why Zoetis (ZTS) is a Strong Growth Stock For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. While you may have an investing s
- StockStory1 Cash-Producing Stock with Competitive Advantages and 2 to Avoid While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses s
- Unknown outlet